Last updated on September 2018

A Phase 3 Randomized Double-blind Placebo-controlled Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)

Brief description of study

The purpose of this study is to evaluate the efficacy of SHP647 in inducing remission, based on composite score of patient-reported symptoms and centrally read endoscopy, in subjects with moderate to severe ulcerative colitis (UC).

Clinical Study Identifier: NCT03259308

Contact Investigators or Research Sites near you

Start Over

Emilio Bermudez Villegas, MD

Centro de Investigacion Clinica Acelerada, S.C.
Distrito Federal, Mexico
  Connect »